Several healthcare insurers have reportedly decided to participate in a new-fangled federal government program intended to lessen the time duration between the actual coverage decision for the medical equipment and the FDA approval. Sources claim that the move has been initiated in a bid to …
St. Louis based Washington University’s researchers have reportedly established a new technique to overcome the blood-brain barrier (BBB), in a bid to administer medications to the brain. Sources familiar with the development claim that these medications would particularly heal brain tumors classified under the difficult-to-treat …
One of the largest pharmaceutical companies in the world, Merck & Co has reportedly gained approval for its cancer drug Keytruda to be officially used in the European countries. According to sources familiar with the development, the drug will be used in association with chemotherapy …
The tezepelumab therapy produced by pharmaceutical giants AstraZeneca and Amgen, has reportedly won the status of being a ‘breakthrough therapy’ in the United States owing to its potential to cure severe asthma, that too without the eosinophilic phenotype. According to sources familiar with the development, …
Roche, a Swiss multinational healthcare company, has reportedly made it to the headlines with regards to its drug pricing issue in Britain. According to sources familiar with the matter, NICE (National Inst. for Health & Care Excellence) has disapproved its drug ‘Ocrevus’ on the grounds …
India’s leading pharmaceutical company, Glenmark Pharmaceuticals Ltd, has reportedly announced that its subsidiary has acquired the marketing authorization in Germany for Fluticasone / Salmeterol DPI (Dry Powder Inhaler). If sources are to be relied on, the product is a generic version of GlaxoSmithKline plc’s (GSK) …
Aterica Inc., a renowned digital health company based in Waterloo, Canada, has recently announced the launch of its Veta™ Smart Case & App for general availability. Veta, is reportedly the first ever comprehensive support system for individuals & their families suffering from food allergy and …
Intermountain Healthcare, headquartered in Salt Lake City, Utah, has officially announced the launch of Civica Rx, a non-profit, hospital-led generic drug company. Aimed at preventing drug shortages and cutting costs, Intermountain Health is supposedly partnering with three philanthropic groups and six other hospital systems to …
Aurobindo Pharma, the second-biggest drugmaker in India, recently announced that it has agreed to buy Sandoz’s dermatology business and a portfolio of its oral solid products in U.S., as well as manufacturing and commercial infrastructure for a total of $900 million. As part of the …
